NCT06836492View on ClinicalTrials.gov

A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

September 30, 2029

Study Completion Date

December 31, 2029

Conditions
RhabdomyosarcomaPediatric Cancer
Interventions
COMBINATION_PRODUCT

VAC，VAC/VII，CAV/IE

Low risk: VAC Intermediate risk: VAC/VII High risk: CAV/IE Very high risk: CAV/VIP

Trial Locations (1)

510060

RECRUITING

Suying Lu, Guangzhou

All Listed Sponsors
lead

Yizhuo Zhang

OTHER